Physician profile
Brian A Roelof
NPI 1821196288
$797.35
in general payments reported to CMS, 2019-2025
10 companies · $47.70 in 2025
The $47.70 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.57 · 2020: $222 · 2021: $82.44 · 2022: $144 · 2023: $65.98 · 2024: $137 · 2025: $47.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $250.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $305.21 | 2020-2023 | |
| Procept Biorobotics Corporation | $184.24 | 2024-2025 | Aquabeam System |
| Medtronic, INC. | $144.04 | 2022 | |
| Janssen Biotech, INC. | $33.96 | 2019-2020 | |
| Rochester Medical Corporation | $31.11 | 2020 | |
| Janssen Scientific Affairs, LLC | $22.50 | 2020 | |
| Sun Pharmaceutical Industries INC. | $22.25 | 2019 | |
| Alexion Pharmaceuticals, INC. | $19.08 | 2019 | |
| Amgen INC. | $19.02 | 2019 | |
| Palette Life Sciences, INC. | $15.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Roelof listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.